ClinicalTrials.Veeva

Menu

Effect of Different Sedation and Analgesia Strategies on Patients With Mechanical Ventilation

Q

Qingdao University

Status and phase

Not yet enrolling
Phase 4

Conditions

Respiratory Insufficiency

Treatments

Drug: Butorphanol and propofol
Drug: fentanyl and dexmedetomindine
Drug: Fentanyl, propofol
Drug: Butorphanol and dexmedetomindine

Study type

Interventional

Funder types

Other

Identifiers

NCT05024799
QYFYKYLL931311920

Details and patient eligibility

About

Most patients in ICU are treated with a combination of analgesics and sedatives in most cases. Due to the different mechanism of different sedative and analgesic drugs, different antagonistic or synergistic effects may occur when combined with drugs, resulting in different clinical effects, especially significant effects on ventilators for patients with assisted breathing. Therefore, this study hopes to compare the effects of different sedative and analgesic drug combinations on the duration of mechanical ventilation for patients with ventilators, so as to guide the clinical adoption of a more reasonable sedative and analgesic scheme.

Enrollment

300 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adults who are treated with sedation and analgesia for invasive mechanical ventilation

Exclusion criteria

  • they have baseline severe cognitive impairment; were pregnant or breast-feeding; were blind, deaf ; had second-degree or third-degree heart block or bradycardia requiring intervention; had an allergy to the experimental drugs; had an indication for benzodiazepines; were anticipated to have immediate discontinuation of mechanical ventilation; were expected to have neuromuscular blockade for more than 48 hours; were in a moribund state; or had received mechanical ventilation for more than 96 hours before meeting all inclusion criteria.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

300 participants in 4 patient groups

F-P group
Experimental group
Description:
the combination of fentanyl and propofol
Treatment:
Drug: Fentanyl, propofol
F-D group
Experimental group
Description:
the combination of fentanyl and dexmedetomidine
Treatment:
Drug: fentanyl and dexmedetomindine
B-P group
Experimental group
Description:
the combination of butorphanol and propofol
Treatment:
Drug: Butorphanol and propofol
B-D group
Experimental group
Description:
the combination of butorphanol and dexmedetomidine
Treatment:
Drug: Butorphanol and dexmedetomindine

Trial contacts and locations

0

Loading...

Central trial contact

Jinyan Xing, Dr

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems